2016 Q4 Form 10-Q Financial Statement

#000117992916000397 Filed on October 27, 2016

View on sec.gov

Income Statement

Concept 2016 Q4 2016 Q3 2015 Q3
Revenue $4.534B $4.546B $3.611B
YoY Change 17.14% 25.89% 45.35%
Cost Of Revenue $3.967B $3.867B $3.050B
YoY Change 20.1% 26.79% 42.66%
Gross Profit $354.0M $471.0M $374.0M
YoY Change -37.63% 25.94% 7.97%
Gross Profit Margin 7.81% 10.36% 10.36%
Selling, General & Admin $536.0M $525.0M $422.7M
YoY Change 15.69% 24.2% 49.68%
% of Gross Profit 151.41% 111.46% 113.02%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $47.00M $46.00M $30.50M
YoY Change 40.72% 50.82% -9.76%
% of Gross Profit 13.28% 9.77% 8.16%
Operating Expenses $573.0M $561.0M $448.6M
YoY Change 16.63% 25.06% 46.27%
Operating Profit -$6.000M $118.0M $113.0M
YoY Change -107.89% 4.42% 182.5%
Interest Expense -$25.00M $26.00M $15.00M
YoY Change 19.62% 73.33% 4.03%
% of Operating Profit 22.03% 13.27%
Other Income/Expense, Net -$26.00M $15.00M
YoY Change -273.33% -198.15%
Pretax Income -$31.00M $92.00M $98.00M
YoY Change -155.06% -6.12% 300.05%
Income Tax $16.00M $50.00M $52.00M
% Of Pretax Income 54.35% 53.06%
Net Earnings -$47.00M $42.00M $46.00M
YoY Change -256.67% -8.7% 187.5%
Net Earnings / Revenue -1.04% 0.92% 1.27%
Basic Earnings Per Share -$0.85 $0.77 $0.84
Diluted Earnings Per Share -$0.85 $0.76 $0.77
COMMON SHARES
Basic Shares Outstanding 56.82M shares 56.00M shares 55.00M shares
Diluted Shares Outstanding 56.00M shares 60.00M shares

Balance Sheet

Concept 2016 Q4 2016 Q3 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.577B $4.577B $3.626B
YoY Change 10.82% 26.24% 48.52%
Cash & Equivalents $2.819B $2.842B $2.164B
Short-Term Investments $1.758B $1.735B $1.462B
Other Short-Term Assets $398.0M $483.0M $120.4M
YoY Change -29.68% 301.04% 46.76%
Inventory
Prepaid Expenses
Receivables $974.0M $1.053B $619.9M
Other Receivables $39.00M $0.00 $0.00
Total Short-Term Assets $5.988B $6.113B $4.910B
YoY Change 12.85% 24.49% 64.36%
LONG-TERM ASSETS
Property, Plant & Equipment $454.0M $450.0M $374.9M
YoY Change 15.52% 20.04% 14.1%
Goodwill $620.0M $619.0M $321.2M
YoY Change 19.46% 92.7% 35.74%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $41.00M $40.00M $36.61M
YoY Change 46.43% 9.25% -28.36%
Total Long-Term Assets $1.461B $1.457B $1.005B
YoY Change 15.04% 45.02% -5.98%
TOTAL ASSETS
Total Short-Term Assets $5.988B $6.113B $4.910B
Total Long-Term Assets $1.461B $1.457B $1.005B
Total Assets $7.449B $7.570B $5.915B
YoY Change 13.28% 27.98% 45.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $385.0M $383.0M $274.1M
YoY Change 6.35% 39.73% -55.02%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $472.0M $466.0M $450.8M
YoY Change 5.12% 3.38% 3679.49%
Total Short-Term Liabilities $4.570B $4.665B $3.861B
YoY Change 19.57% 20.82% 99.43%
LONG-TERM LIABILITIES
Long-Term Debt $975.0M $1.169B $476.5M
YoY Change -15.95% 145.33% -46.87%
Other Long-Term Liabilities $42.00M $39.00M $32.27M
YoY Change 13.51% 20.86% 14.03%
Total Long-Term Liabilities $1.017B $1.208B $32.27M
YoY Change -15.04% 3643.41% 14.03%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.570B $4.665B $3.861B
Total Long-Term Liabilities $1.017B $1.208B $32.27M
Total Liabilities $5.800B $5.879B $4.397B
YoY Change 15.56% 33.7% 42.21%
SHAREHOLDERS EQUITY
Retained Earnings $810.0M $857.0M $728.7M
YoY Change 6.86% 17.6% 25.31%
Common Stock $841.0M $831.0M $789.9M
YoY Change 4.73% 5.2% 106.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.649B $1.691B $1.518B
YoY Change
Total Liabilities & Shareholders Equity $7.449B $7.570B $5.915B
YoY Change 13.28% 27.98% 45.83%

Cashflow Statement

Concept 2016 Q4 2016 Q3 2015 Q3
OPERATING ACTIVITIES
Net Income -$47.00M $42.00M $46.00M
YoY Change -256.67% -8.7% 187.5%
Depreciation, Depletion And Amortization $47.00M $46.00M $30.50M
YoY Change 40.72% 50.82% -9.76%
Cash From Operating Activities $40.00M $355.0M $258.1M
YoY Change -81.75% 37.54% -57.39%
INVESTING ACTIVITIES
Capital Expenditures -$33.00M -$41.00M -$34.50M
YoY Change 4.43% 18.84% 1.17%
Acquisitions
YoY Change
Other Investing Activities -$42.00M $183.0M -$73.70M
YoY Change -94.19% -348.3% -40.95%
Cash From Investing Activities -$75.00M $142.0M -$108.3M
YoY Change -90.06% -231.12% -31.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 8.000M 0.000 400.0K
YoY Change -98.86% -100.0% -99.68%
NET CHANGE
Cash From Operating Activities 40.00M 355.0M 258.1M
Cash From Investing Activities -75.00M 142.0M -108.3M
Cash From Financing Activities 8.000M 0.000 400.0K
Net Change In Cash -27.00M 497.0M 150.2M
YoY Change -116.37% 230.89% -73.7%
FREE CASH FLOW
Cash From Operating Activities $40.00M $355.0M $258.1M
Capital Expenditures -$33.00M -$41.00M -$34.50M
Free Cash Flow $73.00M $396.0M $292.6M
YoY Change -70.89% 35.34% -54.27%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Document Period End Date
DocumentPeriodEndDate
2016-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001179929
CY2016Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
56821000 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
MOLINA HEALTHCARE INC
dei Trading Symbol
TradingSymbol
moh
CY2015Q4 moh Affordable Care Act Premium Stabilization Program Minimum Medical Loss Ratio Receivable Payable
AffordableCareActPremiumStabilizationProgramMinimumMedicalLossRatioReceivablePayable
-3000000 USD
CY2016Q3 moh Affordable Care Act Premium Stabilization Program Minimum Medical Loss Ratio Receivable Payable
AffordableCareActPremiumStabilizationProgramMinimumMedicalLossRatioReceivablePayable
-15000000 USD
CY2016Q3 moh Affordable Care Act Premium Stabilization Program Minimum Medical Loss Ratio Receivable Payable Current Year
AffordableCareActPremiumStabilizationProgramMinimumMedicalLossRatioReceivablePayableCurrentYear
-11000000 USD
CY2016Q3 moh Affordable Care Act Premium Stabilization Program Minimum Medical Loss Ratio Receivable Payable Prior Years
AffordableCareActPremiumStabilizationProgramMinimumMedicalLossRatioReceivablePayablePriorYears
-4000000 USD
CY2015Q4 moh Affordable Care Act Premium Stabilization Program Reinsurance Receivable Payable
AffordableCareActPremiumStabilizationProgramReinsuranceReceivablePayable
36000000 USD
CY2016Q3 moh Affordable Care Act Premium Stabilization Program Reinsurance Receivable Payable
AffordableCareActPremiumStabilizationProgramReinsuranceReceivablePayable
66000000 USD
CY2016Q3 moh Affordable Care Act Premium Stabilization Program Reinsurance Receivable Payable Current Year
AffordableCareActPremiumStabilizationProgramReinsuranceReceivablePayableCurrentYear
62000000 USD
us-gaap Payments To Acquire Additional Interest In Subsidiaries
PaymentsToAcquireAdditionalInterestInSubsidiaries
0 USD
CY2016Q3 moh Affordable Care Act Premium Stabilization Program Reinsurance Receivable Payable Prior Years
AffordableCareActPremiumStabilizationProgramReinsuranceReceivablePayablePriorYears
4000000 USD
CY2015Q4 moh Affordable Care Act Premium Stabilization Program Risk Adjustment Receivable Payable
AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivablePayable
-214000000 USD
CY2016Q3 moh Affordable Care Act Premium Stabilization Program Risk Adjustment Receivable Payable
AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivablePayable
-370000000 USD
CY2016Q3 moh Affordable Care Act Premium Stabilization Program Risk Adjustment Receivable Payable Current Year
AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivablePayableCurrentYear
-372000000 USD
CY2016Q3 moh Affordable Care Act Premium Stabilization Program Risk Adjustment Receivable Payable Prior Years
AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivablePayablePriorYears
2000000 USD
CY2016Q3 moh Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Not Recognized
AffordableCareActPremiumStabilizationProgramRiskCorridorReceivableNotRecognized
80000000 USD
CY2016Q3 moh Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Not Recognized Current Year
AffordableCareActPremiumStabilizationProgramRiskCorridorReceivableNotRecognizedCurrentYear
28000000 USD
CY2016Q3 moh Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Not Recognized Prior Years
AffordableCareActPremiumStabilizationProgramRiskCorridorReceivableNotRecognizedPriorYears
52000000 USD
CY2015Q4 moh Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Payable
AffordableCareActPremiumStabilizationProgramRiskCorridorReceivablePayable
-10000000 USD
CY2016Q3 moh Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Payable
AffordableCareActPremiumStabilizationProgramRiskCorridorReceivablePayable
-5000000 USD
CY2016Q3 moh Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Payable Current Year
AffordableCareActPremiumStabilizationProgramRiskCorridorReceivablePayableCurrentYear
-4000000 USD
CY2016Q3 moh Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Payable Prior Years
AffordableCareActPremiumStabilizationProgramRiskCorridorReceivablePayablePriorYears
-1000000 USD
moh Amortizationof Debt Discount Premiumand Sale Leaseback Financing Obligation
AmortizationofDebtDiscountPremiumandSaleLeasebackFinancingObligation
22000000 USD
moh Amortizationof Debt Discount Premiumand Sale Leaseback Financing Obligation
AmortizationofDebtDiscountPremiumandSaleLeasebackFinancingObligation
23000000 USD
CY2015Q4 moh Anticipated Medicare Risk Adjustment Premiums
AnticipatedMedicareRiskAdjustmentPremiums
-4000000 USD
CY2016Q3 moh Anticipated Medicare Risk Adjustment Premiums
AnticipatedMedicareRiskAdjustmentPremiums
-17000000 USD
moh Business Combination Prepaid Consideration Transferred
BusinessCombinationPrepaidConsiderationTransferred
0 USD
moh Business Combination Prepaid Consideration Transferred
BusinessCombinationPrepaidConsiderationTransferred
-102000000 USD
CY2015Q4 moh Capitation Claims Payable
CapitationClaimsPayable
140000000 USD
CY2016Q3 moh Capitation Claims Payable
CapitationClaimsPayable
27000000 USD
moh Changes In Amounts Due To And Due From Affiliates
ChangesInAmountsDueToAndDueFromAffiliates
0 USD
moh Changes In Amounts Due To And Due From Affiliates
ChangesInAmountsDueToAndDueFromAffiliates
0 USD
moh Class Of Warrant Or Right Trading Days Measurement Period
ClassOfWarrantOrRightTradingDaysMeasurementPeriod
P160D
CY2016Q3 moh Classof Warrantor Right Stated Percentage
ClassofWarrantorRightStatedPercentage
0.01125
CY2015Q3 moh Health Care Organization Insurer Fee Expense
HealthCareOrganizationInsurerFeeExpense
36000000 USD
moh Health Care Organization Insurer Fee Expense
HealthCareOrganizationInsurerFeeExpense
117000000 USD
CY2016Q3 moh Health Care Organization Insurer Fee Expense
HealthCareOrganizationInsurerFeeExpense
55000000 USD
moh Health Care Organization Insurer Fee Expense
HealthCareOrganizationInsurerFeeExpense
163000000 USD
CY2015Q3 moh Health Care Organization Insurer Fee Revenue
HealthCareOrganizationInsurerFeeRevenue
81000000 USD
moh Health Care Organization Insurer Fee Revenue
HealthCareOrganizationInsurerFeeRevenue
203000000 USD
CY2016Q3 moh Health Care Organization Insurer Fee Revenue
HealthCareOrganizationInsurerFeeRevenue
85000000 USD
moh Health Care Organization Insurer Fee Revenue
HealthCareOrganizationInsurerFeeRevenue
251000000 USD
CY2015Q3 moh Health Care Organization Premium Tax Revenue
HealthCareOrganizationPremiumTaxRevenue
99000000 USD
moh Health Care Organization Premium Tax Revenue
HealthCareOrganizationPremiumTaxRevenue
289000000 USD
CY2016Q3 moh Health Care Organization Premium Tax Revenue
HealthCareOrganizationPremiumTaxRevenue
127000000 USD
moh Health Care Organization Premium Tax Revenue
HealthCareOrganizationPremiumTaxRevenue
345000000 USD
moh Increase Decreasein Medical Premium Liability Dueto Agency
IncreaseDecreaseinMedicalPremiumLiabilityDuetoAgency
453000000 USD
moh Increase Decreasein Medical Premium Liability Dueto Agency
IncreaseDecreaseinMedicalPremiumLiabilityDuetoAgency
503000000 USD
CY2015Q4 moh Lease Financing Obligations Noncurrent
LeaseFinancingObligationsNoncurrent
198000000 USD
CY2016Q3 moh Lease Financing Obligations Noncurrent
LeaseFinancingObligationsNoncurrent
198000000 USD
CY2015Q4 moh Medical Claimsand Benefits Payable
MedicalClaimsandBenefitsPayable
167000000 USD
CY2016Q3 moh Medical Claimsand Benefits Payable
MedicalClaimsandBenefitsPayable
237000000 USD
CY2015 moh Medical Claimsand Benefits Payable Adjustments Changein Provider
MedicalClaimsandBenefitsPayableAdjustmentsChangeinProvider
48000000 USD
moh Medical Claimsand Benefits Payable Adjustments Changein Provider
MedicalClaimsandBenefitsPayableAdjustmentsChangeinProvider
70000000 USD
CY2015Q4 moh Medical Premium Liability Dueto Agency
MedicalPremiumLiabilityDuetoAgency
729000000 USD
CY2016Q3 moh Medical Premium Liability Dueto Agency
MedicalPremiumLiabilityDuetoAgency
1232000000 USD
CY2015Q3 moh Net Income Loss From Continuing Operations Before Equity Method Investments Extraordinary Items Noncontrolling Interest
NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest
46000000 USD
moh Net Income Loss From Continuing Operations Before Equity Method Investments Extraordinary Items Noncontrolling Interest
NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest
113000000 USD
CY2016Q3 moh Net Income Loss From Continuing Operations Before Equity Method Investments Extraordinary Items Noncontrolling Interest
NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest
42000000 USD
moh Net Income Loss From Continuing Operations Before Equity Method Investments Extraordinary Items Noncontrolling Interest
NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest
99000000 USD
CY2015Q4 moh Other Claims Payable
OtherClaimsPayable
266000000 USD
CY2016Q3 moh Other Claims Payable
OtherClaimsPayable
397000000 USD
CY2015Q4 moh Pharmacy Claims Payable
PharmacyClaimsPayable
88000000 USD
CY2016Q3 moh Pharmacy Claims Payable
PharmacyClaimsPayable
114000000 USD
CY2015 moh Policy Holder Benefits Prior Percentage
PolicyHolderBenefitsPriorPercentage
0.118
moh Policy Holder Benefits Prior Percentage
PolicyHolderBenefitsPriorPercentage
0.113
CY2015 moh Policy Holder Medical Care Cost Prior Year Percentage
PolicyHolderMedicalCareCostPriorYearPercentage
0.012
moh Policy Holder Medical Care Cost Prior Year Percentage
PolicyHolderMedicalCareCostPriorYearPercentage
0.013
CY2015 moh Policy Holder Premium Revenue Prior Year Percentage
PolicyHolderPremiumRevenuePriorYearPercentage
0.011
moh Policy Holder Premium Revenue Prior Year Percentage
PolicyHolderPremiumRevenuePriorYearPercentage
0.012
CY2015Q3 moh Premium Tax Expenses
PremiumTaxExpenses
99000000 USD
moh Premium Tax Expenses
PremiumTaxExpenses
289000000 USD
CY2016Q3 moh Premium Tax Expenses
PremiumTaxExpenses
127000000 USD
moh Premium Tax Expenses
PremiumTaxExpenses
345000000 USD
CY2015Q3 moh Quality Incentive Premium Revenue As A Percentage Of Total Revenue
QualityIncentivePremiumRevenueAsAPercentageOfTotalRevenue
0.005
moh Quality Incentive Premium Revenue As A Percentage Of Total Revenue
QualityIncentivePremiumRevenueAsAPercentageOfTotalRevenue
0.005
CY2016Q3 moh Quality Incentive Premium Revenue As A Percentage Of Total Revenue
QualityIncentivePremiumRevenueAsAPercentageOfTotalRevenue
0.006
moh Quality Incentive Premium Revenue As A Percentage Of Total Revenue
QualityIncentivePremiumRevenueAsAPercentageOfTotalRevenue
0.011
moh Stock Issued During Period Valueand Income Tax Benefit Relatedto Sharebased Compensation
StockIssuedDuringPeriodValueandIncomeTaxBenefitRelatedtoSharebasedCompensation
28000000 USD
moh Unrecognized Compensation Forfeited Rate
UnrecognizedCompensationForfeitedRate
0.043
CY2015Q3 moh Weighted Average Number Of Shares Issued Under Equity Offering
WeightedAverageNumberOfSharesIssuedUnderEquityOffering
0 shares
moh Weighted Average Number Of Shares Issued Under Equity Offering
WeightedAverageNumberOfSharesIssuedUnderEquityOffering
2000000 shares
CY2016Q3 moh Weighted Average Number Of Shares Issued Under Equity Offering
WeightedAverageNumberOfSharesIssuedUnderEquityOffering
0 shares
moh Weighted Average Number Of Shares Issued Under Equity Offering
WeightedAverageNumberOfSharesIssuedUnderEquityOffering
0 shares
CY2015Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
362000000 USD
CY2016Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
383000000 USD
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4000000 USD
CY2016Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3000000 USD
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P5Y8M
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
803000000 USD
CY2016Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
831000000 USD
CY2015Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7000000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
16000000 USD
CY2016Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8000000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24000000 USD
CY2015Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
7000000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
21000000 USD
CY2016Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
7000000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
22000000 USD
CY2015Q4 us-gaap Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries
AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries
1229000000 USD
CY2016Q3 us-gaap Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries
AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries
1406000000 USD
CY2015Q4 us-gaap Assets
Assets
6576000000 USD
CY2016Q3 us-gaap Assets
Assets
7570000000 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
5306000000 USD
CY2016Q3 us-gaap Assets Current
AssetsCurrent
6113000000 USD
CY2015Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1808000000 USD
CY2016Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1730000000 USD
CY2015Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
1801000000 USD
CY2016Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
1735000000 USD
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2016Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
5000000 USD
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
7000000 USD
CY2016Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2015Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
1000000 USD
CY2015Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
6000000 USD
CY2015Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
1135000000 USD
CY2015Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
119000000 USD
CY2016Q3 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
26000000 USD
CY2016Q3 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
27000000 USD
CY2016Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
817000000 USD
CY2016Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
821000000 USD
CY2016Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
887000000 USD
CY2016Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
887000000 USD
CY2016Q3 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
1735000000 USD
CY2015Q4 us-gaap Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear
846 Security
CY2015Q4 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear
87 Security
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1539000000 USD
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2164000000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2329000000 USD
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2842000000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
625000000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
513000000 USD
CY2013Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
53.8475
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56000000 shares
CY2016Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
57000000 shares
CY2015Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
0 USD
CY2016Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
0 USD
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
48000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
114000000 USD
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
41000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
106000000 USD
CY2015Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
962000000 USD
CY2016Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
971000000 USD
CY2015Q3 us-gaap Costs And Expenses
CostsAndExpenses
3498000000 USD
us-gaap Costs And Expenses
CostsAndExpenses
9996000000 USD
CY2016Q3 us-gaap Costs And Expenses
CostsAndExpenses
4428000000 USD
us-gaap Costs And Expenses
CostsAndExpenses
12936000000 USD
CY2015Q4 us-gaap Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year
CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear
81000000 USD
CY2016Q3 us-gaap Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year
CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear
83000000 USD
CY2013 us-gaap Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
13490236 shares
CY2015Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1553000000 USD
CY2016Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1552000000 USD
CY2015Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
120000000 USD
CY2016Q3 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
96000000 USD
CY2015Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
22000000 USD
CY2016Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
19000000 USD
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
223000000 USD
CY2016Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
380000000 USD
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
18000000 USD
CY2016Q3 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
0 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
0 USD
CY2016Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
6000000 USD
CY2015Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
26000000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
76000000 USD
CY2016Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
36000000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
102000000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
93000000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
135000000 USD
CY2015Q4 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
374000000 USD
CY2016Q3 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
314000000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 USD
CY2015Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
374000000 USD
CY2016Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
314000000 USD
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.84
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.21
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.77
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.79
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.77
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.07
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.76
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.77
CY2016Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
38000000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y7M
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
69000000 USD
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
186000000 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
122000000 USD
CY2016Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
149000000 USD
CY2016Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
343000000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1034000000 USD
CY2015Q4 us-gaap Goodwill
Goodwill
519000000 USD
us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
45000000 USD
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
287000000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
830000000 USD
CY2016Q3 us-gaap Goodwill
Goodwill
619000000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
95000000 USD
CY2015Q3 us-gaap Gross Profit
GrossProfit
374000000 USD
us-gaap Gross Profit
GrossProfit
1114000000 USD
CY2016Q3 us-gaap Gross Profit
GrossProfit
457000000 USD
us-gaap Gross Profit
GrossProfit
1331000000 USD
CY2015Q3 us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
2000000 USD
us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
5000000 USD
CY2016Q3 us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
1000000 USD
us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
4000000 USD
CY2015Q3 us-gaap Health Care Organization Premium Revenue
HealthCareOrganizationPremiumRevenue
3377000000 USD
us-gaap Health Care Organization Premium Revenue
HealthCareOrganizationPremiumRevenue
9652000000 USD
CY2016Q3 us-gaap Health Care Organization Premium Revenue
HealthCareOrganizationPremiumRevenue
4191000000 USD
us-gaap Health Care Organization Premium Revenue
HealthCareOrganizationPremiumRevenue
12215000000 USD
CY2016Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
116000000 USD
CY2016Q3 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
1000000 USD
CY2016Q3 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
1000000 USD
CY2016Q3 us-gaap Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
115000000 USD
CY2016Q3 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
115000000 USD
CY2016Q3 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
116000000 USD
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
98000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
266000000 USD
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
92000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
236000000 USD
CY2015Q3 us-gaap Income Loss From Subsidiaries Net Of Tax
IncomeLossFromSubsidiariesNetOfTax
0 USD
us-gaap Income Loss From Subsidiaries Net Of Tax
IncomeLossFromSubsidiariesNetOfTax
0 USD
CY2016Q3 us-gaap Income Loss From Subsidiaries Net Of Tax
IncomeLossFromSubsidiariesNetOfTax
0 USD
us-gaap Income Loss From Subsidiaries Net Of Tax
IncomeLossFromSubsidiariesNetOfTax
0 USD
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
52000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
153000000 USD
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
50000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
137000000 USD
CY2015Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
13000000 USD
CY2016Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
0 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
34000000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1000000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
30000000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
32000000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
12000000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-20000000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-129000000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
157000000 USD
us-gaap Increase Decrease In Health Care Insurance Liabilities
IncreaseDecreaseInHealthCareInsuranceLiabilities
359000000 USD
us-gaap Increase Decrease In Health Care Insurance Liabilities
IncreaseDecreaseInHealthCareInsuranceLiabilities
168000000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
63000000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
116000000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
23000000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
427000000 USD
us-gaap Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
5000000 USD
us-gaap Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
-4000000 USD
CY2015Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
4000000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
2000000 shares
CY2016Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1000000 shares
CY2015Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
1000000 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
1000000 shares
CY2016Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2015Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1000000 shares
CY2016Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2015Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
641000000 USD
CY2015Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
5000000 USD
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
12000000 USD
CY2016Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
9000000 USD
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
25000000 USD
CY2015Q3 us-gaap Interest Expense
InterestExpense
15000000 USD
us-gaap Interest Expense
InterestExpense
45000000 USD
CY2016Q3 us-gaap Interest Expense
InterestExpense
26000000 USD
us-gaap Interest Expense
InterestExpense
76000000 USD
CY2015Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
10000000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
30000000 USD
CY2016Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
9000000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
30000000 USD
CY2015Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
3000000 USD
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
9000000 USD
CY2016Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
2000000 USD
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
8000000 USD
CY2015Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
0 USD
CY2016Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
0 USD
CY2015Q4 us-gaap Liabilities
Liabilities
5019000000 USD
CY2016Q3 us-gaap Liabilities
Liabilities
5879000000 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6576000000 USD
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7570000000 USD
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
0 USD
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
28000000 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3822000000 USD
CY2015Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
449000000 USD
CY2016Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4665000000 USD
CY2014Q4 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
1201000000 USD
CY2015Q4 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
1685000000 USD
CY2016Q3 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
1871000000 USD
CY2015 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
10448000000 USD
us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
9536000000 USD
CY2015 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
910000000 USD
us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
1278000000 USD
CY2015Q4 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount
1191000000 USD
CY2016Q3 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount
1333000000 USD
CY2015 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
11794000000 USD
us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
10930000000 USD
CY2015Q4 us-gaap Long Term Debt
LongTermDebt
1411000000 USD
CY2016Q3 us-gaap Long Term Debt
LongTermDebt
1437000000 USD
CY2016Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
466000000 USD
CY2016Q3 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
1002000000 USD
CY2016Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
550000000 USD
CY2016Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 USD
CY2016Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0 USD
CY2016Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0 USD
CY2016Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0 USD
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1160000000 USD
CY2016Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1169000000 USD
CY2015Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1801000000 USD
CY2016Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1735000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
384000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-665000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-131000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
906000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
633000000 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
46000000 USD
us-gaap Net Income Loss
NetIncomeLoss
113000000 USD
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
42000000 USD
us-gaap Net Income Loss
NetIncomeLoss
99000000 USD
CY2015Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
15000000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
45000000 USD
CY2016Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
26000000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
76000000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 Segment
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
113000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
311000000 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
118000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
312000000 USD
us-gaap Payments To Acquire Additional Interest In Subsidiaries
PaymentsToAcquireAdditionalInterestInSubsidiaries
0 USD
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
28000000 USD
CY2016Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
40000000 USD
CY2015Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1000000 USD
CY2016Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
7000000 USD
CY2015Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
2000000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
1000000 USD
CY2016Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-3000000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
10000000 USD
CY2015Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0 USD
CY2016Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-2000000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
3000000 USD
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
37000000 USD
CY2016Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
39000000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
13000000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
14000000 USD
CY2015 us-gaap Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
11358000000 USD
us-gaap Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
10814000000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
34000000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
12000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
77000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
48000000 USD
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
101000000 USD
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
143000000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1311000000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1444000000 USD
CY2015Q3 us-gaap Policyholder Benefits And Claims Incurred Health Care
PolicyholderBenefitsAndClaimsIncurredHealthCare
3016000000 USD
us-gaap Policyholder Benefits And Claims Incurred Health Care
PolicyholderBenefitsAndClaimsIncurredHealthCare
8581000000 USD
CY2016Q3 us-gaap Policyholder Benefits And Claims Incurred Health Care
PolicyholderBenefitsAndClaimsIncurredHealthCare
3748000000 USD
us-gaap Policyholder Benefits And Claims Incurred Health Care
PolicyholderBenefitsAndClaimsIncurredHealthCare
10930000000 USD
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2016Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q4 us-gaap Premiums Receivable Gross
PremiumsReceivableGross
3000000 USD
CY2016Q3 us-gaap Premiums Receivable Gross
PremiumsReceivableGross
1000000 USD
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
192000000 USD
CY2016Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
169000000 USD
us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
0 USD
CY2016Q2 us-gaap Shares Outstanding
SharesOutstanding
56000000 shares
CY2016Q3 us-gaap Statutory Accounting Practices Statutory Capital And Surplus Balance
StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
1510000000 USD
CY2016Q3 us-gaap Statutory Accounting Practices Statutory Capital And Surplus Required
StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired
857000000 USD
us-gaap Stock Issued1
StockIssued1
9000000 USD
us-gaap Stock Issued1
StockIssued1
8000000 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
1557000000 USD
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
1691000000 USD
CY2016Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
19000000 USD
CY2015Q3 us-gaap Technology Services Costs
TechnologyServicesCosts
34000000 USD
us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
373000000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
8000000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
10000000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
3000000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
1000000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
863000000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1512000000 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
393000000 USD
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
450000000 USD
CY2015Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
597000000 USD
CY2016Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
1053000000 USD
CY2015Q4 us-gaap Related Party Transaction Due From To Related Party Current
RelatedPartyTransactionDueFromToRelatedPartyCurrent
0 USD
CY2016Q3 us-gaap Related Party Transaction Due From To Related Party Current
RelatedPartyTransactionDueFromToRelatedPartyCurrent
0 USD
CY2015Q4 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
109000000 USD
CY2016Q3 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
116000000 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
758000000 USD
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
857000000 USD
CY2015Q3 us-gaap Revenues
Revenues
3611000000 USD
us-gaap Revenues
Revenues
10307000000 USD
CY2016Q3 us-gaap Revenues
Revenues
4546000000 USD
us-gaap Revenues
Revenues
13248000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
16000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
24000000 USD
CY2014Q4 us-gaap Shares Outstanding
SharesOutstanding
49000000 shares
CY2015Q2 us-gaap Shares Outstanding
SharesOutstanding
55000000 shares
CY2015Q4 us-gaap Shares Outstanding
SharesOutstanding
55000000 shares
us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
134000000 USD
us-gaap Supplemental Deferred Purchase Price
SupplementalDeferredPurchasePrice
-8000000 USD
us-gaap Supplemental Deferred Purchase Price
SupplementalDeferredPurchasePrice
8000000 USD
CY2015 us-gaap Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense
SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
11935000000 USD
us-gaap Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense
SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
11120000000 USD
CY2015 us-gaap Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense
SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
-141000000 USD
us-gaap Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense
SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
-190000000 USD
CY2015Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
0 USD
us-gaap Technology Services Costs
TechnologyServicesCosts
103000000 USD
CY2016Q3 us-gaap Technology Services Costs
TechnologyServicesCosts
119000000 USD
us-gaap Technology Services Costs
TechnologyServicesCosts
362000000 USD
CY2015Q3 us-gaap Technology Services Revenue
TechnologyServicesRevenue
47000000 USD
us-gaap Technology Services Revenue
TechnologyServicesRevenue
146000000 USD
CY2016Q3 us-gaap Technology Services Revenue
TechnologyServicesRevenue
133000000 USD
us-gaap Technology Services Revenue
TechnologyServicesRevenue
408000000 USD
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55000000 shares
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56000000 shares
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51000000 shares
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55000000 shares
us-gaap Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense
ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides the details of our medical claims and benefits payable (including amounts payable for the provision of long-term services and supports, or LTSS) as of the dates indicated.</font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31,<br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fee-for-service claims incurred but not paid (IBNP)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,333</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,191</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pharmacy payable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capitation payable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">140</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">397</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">266</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,871</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,685</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

Files In Submission

Name View Source Status
0001179929-16-000397-index-headers.html Edgar Link pending
0001179929-16-000397-index.html Edgar Link pending
0001179929-16-000397.txt Edgar Link pending
0001179929-16-000397-xbrl.zip Edgar Link pending
exhibit102-2011employeesto.htm Edgar Link pending
exhibit103-amendmentno3mhi.htm Edgar Link pending
exhibit104-2011equityincen.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
moh-06302016x10qex322.htm Edgar Link pending
moh-09302016x10q.htm Edgar Link pending
moh-09302016x10qex311.htm Edgar Link pending
moh-09302016x10qex312.htm Edgar Link pending
moh-09302016x10qex321.htm Edgar Link pending
moh-20160930.xml Edgar Link completed
moh-20160930.xsd Edgar Link pending
moh-20160930_cal.xml Edgar Link unprocessable
moh-20160930_def.xml Edgar Link unprocessable
moh-20160930_lab.xml Edgar Link unprocessable
moh-20160930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending